Cargando…
Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion
Rationale: Bladder cancer (BC) management demands the introduction of novel molecular targets for precision medicine. Cell surface glycoprotein CD44 has been widely studied as a potential biomarker of BC aggressiveness and cancer stem cells. However, significant alternative splicing and multiple gly...
Autores principales: | Gaiteiro, Cristiana, Soares, Janine, Relvas-Santos, Marta, Peixoto, Andreia, Ferreira, Dylan, Paulo, Paula, Brandão, Andreia, Fernandes, Elisabete, Azevedo, Rita, Palmeira, Carlos, Freitas, Rui, Miranda, Andreia, Osório, Hugo, Prieto, Jesús, Lima, Luís, Silva, André M. N., Santos, Lúcio Lara, Ferreira, José Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065180/ https://www.ncbi.nlm.nih.gov/pubmed/35547758 http://dx.doi.org/10.7150/thno.67409 |
Ejemplares similares
-
Glycoproteogenomics: Setting the Course for Next-generation Cancer Neoantigen Discovery for Cancer Vaccines
por: Ferreira, José Alexandre, et al.
Publicado: (2021) -
CD44 glycoprotein in cancer: a molecular conundrum hampering clinical applications
por: Azevedo, Rita, et al.
Publicado: (2018) -
Nucleolin-Sle A Glycoforms as E-Selectin Ligands and Potentially Targetable Biomarkers at the Cell Surface of Gastric Cancer Cells
por: Fernandes, Elisabete, et al.
Publicado: (2020) -
Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer
por: Peixoto, Andreia, et al.
Publicado: (2021) -
Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?
por: Azevedo, Rita, et al.
Publicado: (2017)